"The InterSePT Study: A Treatment for Suicidality in Schizophrenia"
This event is in the past.
1 p.m. to 2 p.m.
Wayne State University School of Medicine
Dept. of Psychiatry and Behavioral Neurosciences
Chairman's Grand Rounds - Elliot Luby Endowed Lectureship
Date: Jan. 28, 2026
Time: 1-2pm
Venue: Margherio Family Conference Center
Speaker: Larry Alphs, MD, PhD - CEO, Larry Alphs Consulting, LLC, Princeton, New Jersey
Commercial Relationship:
Past Financial Relationship during the last 24 months -
Consultation: Roche Genentech and Merck
Current Commercial Relationship:
Consultant: Otsuka Biopharma, Denovo Biopharma, NetraMark, Neushen Biopharma, and Neumaker
Topic: The InterSePT Study: A Treatment for Suicidality in Schizophrenia
Objectives:
1. Describe the need for management of suicidality when treating persons with schizophrenia.
2. Identify hurdles to the design of InterSePT trial and the challenges it presented.
3. Identify application of InterSePT findings to clinical practice.